⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

RGEN

Repligen Corporation

Healthcare · Medical Instruments & Supplies

165.05USD

-3.4800 (-2.06%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY801.5M632.4M634.4M738.3M827.0M968.6M
Q1206.4M165.4M153.2M169.2M194.3M—
Q2207.6M159.2M158.8M182.4M204.1M—
Q3200.7M141.2M154.9M188.8M206.8M—
Q4186.8M*166.6M*167.5M*197.9M*222.0M—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY.003.001-.000.0012.062.64
Q1.001.000.000.100.150—
Q2.001.000.000.259.090—
Q3.001.000-.000.000.463—
Q4.847*

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

-.291*
-.605*
.235*
.580
—